Cite
Developing glutathione-activated catechol-type diphenylpolyenes as small molecule-based and mitochondria-targeted prooxidative anticancer theranostic prodrugs.
MLA
Bao, Xia-Zhen, et al. “Developing Glutathione-Activated Catechol-Type Diphenylpolyenes as Small Molecule-Based and Mitochondria-Targeted Prooxidative Anticancer Theranostic Prodrugs.” Free Radical Biology & Medicine, vol. 134, Apr. 2019, pp. 406–18. EBSCOhost, https://doi.org/10.1016/j.freeradbiomed.2019.01.033.
APA
Bao, X.-Z., Dai, F., Wang, Q., Jin, X.-L., & Zhou, B. (2019). Developing glutathione-activated catechol-type diphenylpolyenes as small molecule-based and mitochondria-targeted prooxidative anticancer theranostic prodrugs. Free Radical Biology & Medicine, 134, 406–418. https://doi.org/10.1016/j.freeradbiomed.2019.01.033
Chicago
Bao, Xia-Zhen, Fang Dai, Qi Wang, Xiao-Ling Jin, and Bo Zhou. 2019. “Developing Glutathione-Activated Catechol-Type Diphenylpolyenes as Small Molecule-Based and Mitochondria-Targeted Prooxidative Anticancer Theranostic Prodrugs.” Free Radical Biology & Medicine 134 (April): 406–18. doi:10.1016/j.freeradbiomed.2019.01.033.